Files size/type shown when available.
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
This opportunity involves the provision of Lutathera and Pluvicto isotopes for the Department of Veterans Affairs. Companies specializing in pharmaceutical products, especially isotopes and radiopharmaceuticals, should assess their capacity to respond to this award notice.
The buyer aims to procure Lutathera and Pluvicto isotopes for healthcare provision to veterans, ensuring availability and compliance with regulations pertaining to pharmaceutical supplies.
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.
Awarded-market signal for NAICS 325412 (last 12 months), benchmarked to sector 32.
